By Associate Professor Anthony Newall

Journal articles

Newall AT; Jit M; Beutels P, 2011, 'PIN42 Methodological Decisions in Economic Evaluations of Childhood Influenza Vaccination: Findings from a Literature Review', Value in Health, 14, pp. A273 - A273, http://dx.doi.org/10.1016/j.jval.2011.08.229

Newall AT; Scuffham P, 2011, 'Uncertainty and variability in influenza cost-effectiveness models', Australian and New Zealand Journal of Public Health, 35, pp. 576 - 576, http://dx.doi.org/10.1111/j.1753-6405.2011.00788.x

Newall AT; Wood JG; Oudin N; MacIntyre CR, 2010, 'Cost-effectiveness of pharmaceutical-based pandemic influenza mitigation strategies', Emerging Infectious Diseases, 16, pp. 224 - 230, http://dx.doi.org/10.3201/eid1602.090571

Newall AT; Viboud C; Wood JG, 2010, 'Influenza-attributable mortality in Australians aged more than 50 years: A comparison of different modelling approaches', Epidemiology and Infection, 138, pp. 836 - 842, http://dx.doi.org/10.1017/S095026880999118X

Newall AT; Kelly H; Harsley S; Scuffham P, 2009, 'Cost effectiveness of influenza vaccination in older adults: A critical review of economic evaluations for the 50- to 64-year age group', Pharmacoeconomics, 27, pp. 439 - 450, http://dx.doi.org/10.2165/00019053-200927060-00001

Inglis E; Kesson AM; Newall AT; Macartney K; MacIntyre CR, 2009, 'The burden of rotavirus gastroenteritis in children presenting to a paediatric hospital', Epidemiology and Infection, 137, pp. 943 - 949, http://dx.doi.org/10.1017/S0950268808001520

, 2008, 'Pappas et al. (2007; 45:883–93)', Clinical Infectious Diseases, 47, pp. 302 - 302, http://dx.doi.org/10.1086/590000

Newall AT; Brotherton JML; Quinn HE; McIntyre PB; Backhouse J; Gilbert L; Esser MT; Erick J; Bryan J; Formica N; MacIntyre CR, 2008, 'Population seroprevalence of human papillomavirus types 6, 11, 16, and 18 in men, women, and children in Australia (vol 46, pg 1647, 2008)', CLINICAL INFECTIOUS DISEASES, 47, pp. 302 - 302, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000256905000033&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Newall AT; Scuffham P, 2008, 'Influenza-related disease: The cost to the Australian healthcare system', Vaccine, 26, pp. 6818 - 6823, http://dx.doi.org/10.1016/j.vaccine.2008.09.086

Newall AT; Wood JG; MacIntyre CR, 2008, 'Influenza-related hospitalisation and death in Australians aged 50 years and older', Vaccine, 26, pp. 2135 - 2141, http://dx.doi.org/10.1016/j.vaccine.2008.01.051

Kelly H; Newall AT, 2008, 'Mortality benefits of influenza vaccination in elderly people', Lancet Infectious Diseases, 8, pp. 462 - 463, http://dx.doi.org/10.1016/S1473-3099(08)70163-4

Newall AT; Brotherton J; Quinn H; McIntyre P; Backhouse J; Gilbert LG; Esser MT; Erick J; Bryan J; Formica N; MacIntyre CR, 2008, 'Population seroprevalence of human papillomavirus types 6, 11, 16, and 18 in men, women, and children in Australia', Clinical Infectious Diseases, 46, pp. 1647 - 1655, http://dx.doi.org/10.1086/587895

Newall AT; Scuffham P; Kelly H; Harsley S; MacIntyre CR, 2008, 'The cost-effectiveness of a universal influenza vaccination program for adults aged 50-64 years in Australia', Vaccine, 26, pp. 2142 - 2153, http://dx.doi.org/10.1016/j.vaccine.2008.01.050

Harsley SR; Kelly HA; MacIntyre R; Newall AT; Scuffham PA, 2007, 'The cost-effectiveness of universal influenza vaccination for 50-64 year-olds in Australia', VALUE IN HEALTH, 10, pp. A444 - A444, http://dx.doi.org/10.1016/S1098-3015(10)65534-9

Newall AT; Beutels P; Wood JG; Edmunds WJ; MacIntyre CR, 2007, 'Cost-effectiveness analyses of human papillomavirus vaccination', Lancet Infectious Diseases, 7, pp. 289 - 296, http://dx.doi.org/10.1016/S1473-3099(07)70083-X

McIntyre P; Amin J; Gidding H; Hull B; Torvaldsen S; Tucker A; Turnbull F; Burgess M, 2000, 'Vaccine preventable diseases and vaccination coverage in Australia, 1993-1998.', Communicable Diseases Intelligence, Suppl

Back to profile page